查詢結果分析
來源資料
頁籤選單縮合
題名 | CDA-Ⅱ,人尿製劑的抗氧化作用=The Antioxidant Activities of CDA-Ⅱ, Urinary Preparation |
---|---|
作者 | 賴東淵; 賴基銘; 賴易成; 蔡金川; 陳俊明; Lai, Tung-yuan; Lai, Gi-ming; Lai, Eric Y. C.; Tsai, Chin-chuan; |
期刊 | 臺灣中醫醫學雜誌 |
出版日期 | 20020300 |
卷期 | 1:2 2002.03[民91.03] |
頁次 | 頁38-49 |
分類號 | 414.5 |
語文 | chi |
關鍵詞 | 人尿製劑; 抗氧化作用; CDA-Ⅱ; Urinary preparation; Antioxidant; |
中文摘要 | 由於人類種種疾病的病因皆與自由基氧化應激有關,因此人尿的療效 可能經由清除自由基的能力產生。本實驗皆在證明CDA-II, 人尿製劑是否也能 清除自由基。 CDS-II, 人尿製劑能抑制腦均漿的自發性氧化反應。另由鐵及維生素C誘發 的脂質過氧化作用,對肝均漿的抑制作用強於對腦均的抑制作用。體內的實驗也 顯示,口服CDA-II, 人連製劑也能提升大鼠血漿中的抗氧化能力。 |
英文摘要 | Since free radical oxidative stress has been implicated in the pathogenesis of a variety of human disease, these therapeutical properties of human urine seem to be due to its ability to scavenge free radicals. The studies on spontaneous autoxidation of rat brain homogenates showed that CDA-II has an inhibitory effect. In addition, the studies on rat brain and liver lipid peroxidation induced by Fe (III)/ascorbic acid showed that CDA-II has a stronger inhibitiory action on liver homogenates than brain homogenates. In vivo studies also showed that oral administration of CDA-II increased the antioxidant ability of plasma from rat. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。